Home Journals Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance

Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance

Credits to the Source Link Daniel
Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance
    • Raimondo G.
    • Locarnini S.
    • Pollicino T.
    • Levrero M.
    • Zoulim F.
    • Lok A.S.
    • et al.

    Update of the statements on biology and clinical impact of occult hepatitis B virus infection.

    J Hepatol. 2019; 71: 397-408

  • Hepatitis B virus infection and transfusion medicine: science and the occult.

    Transfusion. 2008; 48: 1001-1026

  • Occult hepatitis B.

    Lancet Infect Dis. 2002; 2: 479-486

    • Mulrooney-Cousins P.M.
    • Michalak T.I.

    Asymptomatic Hepadnaviral Persistence and Its Consequences in the Woodchuck Model of Occult Hepatitis B Virus Infection.

    J Clin Transl Hepatol. 2015; 3: 211-219

    • Michalak T.I.
    • Pardoe I.U.
    • Coffin C.S.
    • Churchill N.D.
    • Freake D.S.
    • Smith P.
    • et al.

    Occult lifelong persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis.

    Hepatology. 1999; 29: 928-938

    • Blackberg J.
    • Kidd-Ljunggren K.

    Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation.

    Journal of hepatology. 2000; 33: 992-997

  • Hepatitis B virus pre-S/S variants in liver diseases.

    World J Gastroenterol. 2018; 24: 1507-1520

    • Su H.
    • Zhang Y.
    • Xu D.
    • Wang B.
    • Zhang L.
    • Li D.
    • et al.

    Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China.

    PLoS One. 2013; 8e70768

    • Mu S.C.
    • Lin Y.M.
    • Jow G.M.
    • Chen B.F.

    Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.

    J Hepatol. 2009; 50: 264-272

    • Shahmoradi S.
    • Yahyapour Y.
    • Mahmoodi M.
    • Alavian S.M.
    • Fazeli Z.
    • Jazayeri S.M.

    High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG.

    J Hepatol. 2012; 57: 515-521

    • Pande C.
    • Sarin S.K.
    • Patra S.
    • Kumar A.
    • Mishra S.
    • Srivastava S.
    • et al.

    Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial.

    J Viral Hepat. 2013; 20: 801-810

    • Bes M.
    • Vargas V.
    • Piron M.
    • Casamitjana N.
    • Esteban J.I.
    • Vilanova N.
    • et al.

    T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.

    J Hepatol. 2012; 56: 765-774

    • Rehermann B.
    • Ferrari C.
    • Pasquinelli C.
    • Chisari F.V.

    The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

    Nat Med. 1996; 2: 1104-1108

    • Penna A.
    • Artini M.
    • Cavalli A.
    • Levrero M.
    • Bertoletti A.
    • Pilli M.
    • et al.

    Long-lasting memory T cell responses following self-limited acute hepatitis B.

    J Clin Invest. 1996; 98: 1185-1194

    • Shinkai N.
    • Matsuura K.
    • Sugauchi F.
    • Watanabe T.
    • Murakami S.
    • Iio E.
    • et al.

    Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.

    J Clin Microbiol. 2013; 51: 3484-3491

    • Takeda K.
    • Maruki M.
    • Yamagaito T.
    • Muramatsu M.
    • Sakai Y.
    • Tobimatsu H.
    • et al.

    Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.

    J Clin Microbiol. 2013; 51: 2238-2244

    • Wong D.K.
    • Cheng S.C.Y.
    • Mak L.L.
    • To E.W.
    • Lo R.C.
    • Cheung T.T.
    • et al.

    Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.

    Clin Gastroenterol Hepatol. 2020; 18: 449-456

  • Occult hepatitis B virus infection.

    Transfus Clin Biol. 2004; 11: 18-25

    • Iizuka H.
    • Ohmura K.
    • Ishijima A.
    • Satoh K.
    • Tanaka T.
    • Tsuda F.
    • et al.

    Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg.

    Vox Sang. 1992; 63: 107-111

    • Alavian S.M.
    • Miri S.M.
    • Hollinger F.B.
    • Jazayeri S.M.

    Occult Hepatitis B (OBH) in Clinical Settings.

    Hepat Mon. 2012; 12e6126

  • Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review.

    J Viral Hepat. 2014; 21: 153-162

  • Occult hepatitis B virus infection: a covert operation.

    J Viral Hepat. 2010; 17: 1-15

    • Hu L.P.
    • Liu D.P.
    • Chen Q.Y.
    • Harrison T.J.
    • He X.
    • Wang X.Y.
    • et al.

    Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection.

    PLoS One. 2015; 10e0138552

    • Seed C.R.
    • Allain J.P.
    • Lozano M.
    • Laperche S.
    • Gallian P.
    • Gross S.
    • et al.

    International forum on Occult hepatitis B infection and transfusion safety.

    Vox Sang. 2019; 114: 397-406

    • Lelie N.
    • Bruhn R.
    • Busch M.
    • Vermeulen M.
    • Tsoi W.C.
    • Kleinman S.
    • et al.

    Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing.

    Transfusion. 2017; 57: 24-35

    • Candotti D.
    • Lin C.K.
    • Belkhiri D.
    • Sakuldamrongpanich T.
    • Biswas S.
    • Lin S.
    • et al.

    Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.

    Gut. 2012; 61: 1744-1753

    • Caviglia G.P.
    • Pellicano R.
    • Saracco G.M.
    • Smedile A.

    Hepatitis B Core-Related Antigen: A Serum Biomarker for Intrahepatic Covalently-Closed-Circular DNA.

    Clin Lab. 2018; 64: 411-412

    • Candotti D.
    • Assennato S.M.
    • Laperche S.
    • Allain J.P.
    • Levicnik-Stezinar S.

    Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose.

    Gut. 2019; 68: 313-321

    • Seed C.R.
    • Maloney R.
    • Kiely P.
    • Bell B.
    • Keller A.J.
    • Pink J.
    • et al.

    Infectivity of blood components from donors with occult hepatitis B infection – results from an Australian lookback programme.

    Vox Sang. 2015; 108: 113-122

    • Satake M.
    • Taira R.
    • Yugi H.
    • Hino S.
    • Kanemitsu K.
    • Ikeda H.
    • et al.

    Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.

    Transfusion. 2007; 47: 1197-1205

    • Lieshout-Krikke R.W.
    • van Kraaij M.G.
    • Danovic F.
    • Zaaijer H.L.

    Rare transmission of hepatitis B virus by Dutch donors with occult infection.

    Transfusion. 2016; 56: 691-698

    • Taira R.
    • Satake M.
    • Momose S.
    • Hino S.
    • Suzuki Y.
    • Murokawa H.
    • et al.

    Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.

    Transfusion. 2013; 53: 1393-1404

    • Allain J.P.
    • Mihaljevic I.
    • Gonzalez-Fraile M.I.
    • Gubbe K.
    • Holm-Harritshoj L.
    • Garcia J.M.
    • et al.

    Infectivity of blood products from donors with occult hepatitis B virus infection.

    Transfusion. 2013; 53: 1405-1415

  • Ferguson M, Health A, Lelie N, ubling M, Nick S, Gerlich W, et al. WHO Working Group on Hepatitis and HIV Diagnostic Kits : report of a collaborative study to 1) assess the suitability of candidate replacement international standard for HBsAG and a reference panel for HBsAG and 2) to calibrate the candidate standard in IU. World Health Organization. 2003.

    • Hsia C.C.
    • Purcell R.H.
    • Farshid M.
    • Lachenbruch P.A.
    • Yu M.Y.

    Quantification of hepatitis B virus genomes and infectivity in human serum samples.

    Transfusion. 2006; 46: 1829-1835

    • Huang X.
    • Qin Y.
    • Li W.
    • Shi Q.
    • Xue Y.
    • Li J.
    • et al.

    Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B.

    J Med Virol. 2013; 85: 979-986

    • Huang X.
    • Ma C.
    • Zhang Q.
    • Shi Q.
    • Huang T.
    • Liu C.
    • et al.

    Impact of “a” determinant mutations on detection of hepatitis B surface antigen (HBsAg) in HBV strains from Chinese patients with occult hepatitis B.

    J Med Virol. 2017; 89: 1796-1803

    • Zhang L.
    • Chang L.
    • Laperche S.
    • Ji H.
    • Zhao J.
    • Jiang X.
    • et al.

    Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains.

    Emerg Microbes Infect. 2019; 8: 1337-1346

    • Zhang K.
    • Liu Y.
    • Chen R.
    • Li Q.
    • Xu Z.
    • Si L.
    • et al.

    Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection.

    J Med Virol. 2018; 90: 263-270

    • Vivekanandan P.
    • Kannangai R.
    • Ray S.C.
    • Thomas D.L.
    • Torbenson M.

    Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples.

    Clin Infect Dis. 2008; 46: 1227-1236

    • Huang F.Y.
    • Wong D.K.
    • Seto W.K.
    • Zhang A.Y.
    • Lee C.K.
    • Lin C.K.
    • et al.

    Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection.

    PLoS One. 2014; 9e99028

    • Pollicino T.
    • Raffa G.
    • Costantino L.
    • Lisa A.
    • Campello C.
    • Squadrito G.
    • et al.

    Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma.

    Hepatology. 2007; 45: 277-285

    • Yuen M.F.
    • Wong D.K.
    • Lee C.K.
    • Tanaka Y.
    • Allain J.P.
    • Fung J.
    • et al.

    Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection.

    Clin Infect Dis. 2011; 52: 624-632

    • Chazouilleres O.
    • Mamish D.
    • Kim M.
    • Carey K.
    • Ferrell L.
    • Roberts J.P.
    • et al.

    Occult Hepatitis-B Virus as Source of Infection in Liver-Transplant Recipients.

    Lancet. 1994; 343: 142-146

    • Seto W.K.
    • Chan T.S.
    • Hwang Y.Y.
    • Wong D.K.
    • Fung J.
    • Liu K.S.
    • et al.

    Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.

    J Clin Oncol. 2014; 32: 3736-3743

    • Seto W.K.
    • Sau-Yan Chan T.
    • Hwang Y.Y.
    • Wong D.K.
    • Fung J.
    • Liu K.S.
    • et al.

    Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study.

    Hepatology. 2016;

  • Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.

    Gastroenterology. 2017; 152: 1297-1309

    • Pollicino T.
    • Squadrito G.
    • Cerenzia G.
    • Cacciola I.
    • Raffa G.
    • Crax A.
    • et al.

    Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

    Gastroenterology. 2004; 126: 102-110

    • Wong D.K.
    • Huang F.Y.
    • Lai C.L.
    • Poon R.T.
    • Seto W.K.
    • Fung J.
    • et al.

    Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.

    Hepatology. 2011; 54: 829-836

    • Guo Y.
    • Li Y.
    • Mu S.
    • Zhang J.
    • Yan Z.

    Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication.

    J Med Virol. 2009; 81: 1177-1183

    • Zhang Y.
    • Mao R.
    • Yan R.
    • Cai D.
    • Zhang Y.
    • Zhu H.
    • et al.

    Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection.

    PLoS One. 2014; 9e110442

  • Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B.

    Hepatology. 2017; 66: 2066-2077

    • Bock C.T.
    • Schwinn S.
    • Locarnini S.
    • Fyfe J.
    • Manns M.P.
    • Trautwein C.
    • et al.

    Structural organization of the hepatitis B virus minichromosome.

    J Mol Biol. 2001; 307: 183-196

    • Pollicino T.
    • Belloni L.
    • Raffa G.
    • Pediconi N.
    • Squadrito G.
    • Raimondo G.
    • et al.

    Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.

    Gastroenterology. 2006; 130: 823-837

    • Belloni L.
    • Pollicino T.
    • De Nicola F.
    • Guerrieri F.
    • Raffa G.
    • Fanciulli M.
    • et al.

    Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

    Proc Natl Acad Sci U S A. 2009; 106: 19975-19979

    • Chong C.K.
    • Cheng C.Y.S.
    • Tsoi S.Y.J.
    • Huang F.Y.
    • Liu F.
    • Seto W.K.
    • et al.

    Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome.

    Antiviral Research. 2017; 144: 1-7

    • Chong C.K.
    • Cheng C.Y.S.
    • Tsoi S.Y.J.
    • Huang F.Y.
    • Liu F.
    • Fung J.
    • et al.

    HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA.

    Sci Rep. 2020; 10: 802

    • Belloni L.
    • Allweiss L.
    • Guerrieri F.
    • Pediconi N.
    • Volz T.
    • Pollicino T.
    • et al.

    IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome.

    J Clin Invest. 2012; 122: 529-537

    • Benhenda S.
    • Ducroux A.
    • Riviere L.
    • Sobhian B.
    • Ward M.D.
    • Dion S.
    • et al.

    Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

    J Virol. 2013; 87: 4360-4371

    • Zhang W.
    • Chen J.
    • Wu M.
    • Zhang X.
    • Zhang M.
    • Yue L.
    • et al.

    PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.

    Hepatology. 2017; 66: 398-415

    • Deng J.J.
    • Kong K.E.
    • Gao W.W.
    • Tang H.V.
    • Chaudhary V.
    • Cheng Y.
    • et al.

    Interplay between SIRT1 and hepatitis B virus X protein in the activation of viral transcription.

    Biochim Biophys Acta Gene Regul Mech. 2017; 1860: 491-501

    • Levrero M.
    • Pollicino T.
    • Petersen J.
    • Belloni L.
    • Raimondo G.
    • Dandri M.

    Control of cccDNA function in hepatitis B virus infection.

    J Hepatol. 2009; 51: 581-592

    • Zerbini A.
    • Pilli M.
    • Boni C.
    • Fisicaro P.
    • Penna A.
    • Di Vincenzo P.
    • et al.

    The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.

    Gastroenterology. 2008; 134: 1470-1481

    • Korba B.E.
    • Wells F.V.
    • Baldwin B.
    • Cote P.J.
    • Tennant B.C.
    • Popper H.
    • et al.

    Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections.

    Hepatology. 1989; 9: 461-470

    • Michalak T.I.
    • Mulrooney P.M.
    • Coffin C.S.

    Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver.

    J Virol. 2004; 78: 1730-1738

    • Gujar S.A.
    • Mulrooney-Cousins P.M.
    • Michalak T.I.

    Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis.

    J Virol. 2013; 87: 1035-1048

  • FDA: Increased HBV reactivation risk with ofatumumab or rituximab.

    JAMA. 2013; 310: 1664

    • Williams J.B.
    • Huppner A.
    • Mulrooney-Cousins P.M.
    • Michalak T.I.

    Differential Expression of Woodchuck Toll-Like Receptors 1-10 in Distinct Forms of Infection and Stages of Hepatitis in Experimental Hepatitis B Virus Infection.

    Front Microbiol. 2018; 9: 3007

    • Mulrooney-Cousins P.M.
    • Chauhan R.
    • Churchill N.D.
    • Michalak T.I.

    Primary seronegative but molecularly evident hepadnaviral infection engages liver and induces hepatocarcinoma in the woodchuck model of hepatitis B.

    PLoS Pathog. 2014; 10e1004332

    • Yuen M.F.
    • Wong D.K.
    • Fung J.
    • Ip P.
    • But D.
    • Hung I.
    • et al.

    HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

    Gastroenterology. 2008; 135: 1192-1199

    • Yip T.C.
    • Chan H.L.
    • Wong V.W.
    • Tse Y.K.
    • Lam K.L.
    • Wong G.L.

    Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

    J Hepatol. 2017; 67: 902-908

    • Fang Y.
    • Shang Q.L.
    • Liu J.Y.
    • Li D.
    • Xu W.Z.
    • Teng X.
    • et al.

    Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.

    J Infect. 2009; 58: 383-388

    • Ikeda K.
    • Kobayashi M.
    • Someya T.
    • Saitoh S.
    • Hosaka T.
    • Akuta N.
    • et al.

    Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.

    J Viral Hepat. 2009; 16: 437-443

    • Shi Y.
    • Wu Y.H.
    • Wu W.
    • Zhang W.J.
    • Yang J.
    • Chen Z.

    Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.

    Liver Int. 2012; 32: 231-240

    • Yotsuyanagi H.
    • Shintani Y.
    • Moriya K.
    • Fujie H.
    • Tsutsumi T.
    • Kato T.
    • et al.

    Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.

    J Infect Dis. 2000; 181: 1920-1928

    • Chen C.H.
    • Changchien C.S.
    • Lee C.M.
    • Tung W.C.
    • Hung C.H.
    • Hu T.H.
    • et al.

    A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.

    Int J Cancer. 2009; 125: 621-629

    • Tanaka T.
    • Inoue K.
    • Hayashi Y.
    • Abe A.
    • Tsukiyama-Kohara K.
    • Nuriya H.
    • et al.

    Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease.

    J Med Virol. 2004; 72: 223-229

    • Branco F.
    • Mattos A.A.
    • Coral G.P.
    • Vanderborght B.
    • Santos D.E.
    • Franca P.
    • et al.

    Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil.

    Arq Gastroenterol. 2007; 44: 58-63

    • Obika M.
    • Shinji T.
    • Fujioka S.
    • Terada R.
    • Ryuko H.
    • Lwin A.A.
    • et al.

    Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.

    Intervirology. 2008; 51: 59-68

    • Koike K.
    • Shimotouno K.
    • Okada S.
    • Okamoto H.
    • Hayashi N.
    • Ueda K.
    • et al.

    Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan.

    Jpn J Cancer Res. 1999; 90: 1270-1272

    • Momosaki S.
    • Nakashima Y.
    • Kojiro M.
    • Tabor E.

    HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

    J Viral Hepat. 2005; 12: 325-329

    • Lok A.S.
    • Everhart J.E.
    • Di Bisceglie A.M.
    • Kim H.Y.
    • Hussain M.
    • Morgan T.R.
    • et al.

    Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.

    Hepatology. 2011; 54: 434-442

    • Kao J.H.
    • Chen P.J.
    • Lai M.Y.
    • Chen D.S.

    Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C.

    J Clin Microbiol. 2002; 40: 4068-4071

    • El-Maksoud M.A.
    • Habeeb M.R.
    • Ghazy H.F.
    • Nomir M.M.
    • Elalfy H.
    • Abed S.
    • et al.

    Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.

    Eur J Gastroenterol Hepatol. 2019; 31: 716-722

    • Squadrito G.
    • Pollicino T.
    • Cacciola I.
    • Caccamo G.
    • Villari D.
    • La Masa T.
    • et al.

    Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.

    Cancer. 2006; 106: 1326-1330

    • Squadrito G.
    • Cacciola I.
    • Alibrandi A.
    • Pollicino T.
    • Raimondo G.

    Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.

    J Hepatol. 2013; 59: 696-700

    • Miura Y.
    • Shibuya A.
    • Adachi S.
    • Takeuchi A.
    • Tsuchihashi T.
    • Nakazawa T.
    • et al.

    Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails.

    Hepatol Res. 2008; 38: 546-556

    • Matsuoka S.
    • Nirei K.
    • Tamura A.
    • Nakamura H.
    • Matsumura H.
    • Oshiro S.
    • et al.

    Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.

    Intervirology. 2008; 51: 352-361

    • Raimondo G.
    • Caccamo G.
    • Filomia R.
    • Pollicino T.

    Occult HBV infection.

    Semin Immunopathol. 2013; 35: 39-52

  • Current Knowledge of Occult Hepatitis B Infection and Clinical Implications.

    Semin Liver Dis. 2019; 39: 249-260

  • Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: Old and new paradigms.

    Gastroenterology. 2004; 127: S56-S61

    • Chen X.P.
    • Long X.
    • Jia W.L.
    • Wu H.J.
    • Zhao J.
    • Liang H.F.
    • et al.

    Viral integration drives multifocal HCC during the occult HBV infection.

    J Exp Clin Cancer Res. 2019; 38: 261

    • Fujimoto A.
    • Furuta M.
    • Totoki Y.
    • Tsunoda T.
    • Kato M.
    • Shiraishi Y.
    • et al.

    Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.

    Nat Genet. 2016; 48: 500-509

    • Saitta C.
    • Tripodi G.
    • Barbera A.
    • Bertuccio A.
    • Smedile A.
    • Ciancio A.
    • et al.

    Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.

    Liver Int. 2015; 35: 2311-2317

    • Murakami Y.
    • Saigo K.
    • Takashima H.
    • Minami M.
    • Okanoue T.
    • Brechot C.
    • et al.

    Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.

    Gut. 2005; 54: 1162-1168

    • Tamori A.
    • Nishiguchi S.
    • Kubo S.
    • Enomoto M.
    • Koh N.
    • Takeda T.
    • et al.

    Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.

    J Med Virol. 2003; 69: 475-481

    • Levrero M.
    • Zucman-Rossi J.

    Mechanisms of HBV-induced hepatocellular carcinoma.

    J Hepatol. 2016; 64: S84-S101

    • Bonilla Guerrero R.
    • Roberts L.R.

    The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma.

    J Hepatol. 2005; 42: 760-777

    • Urashima T.
    • Saigo K.
    • Kobayashi S.
    • Imaseki H.
    • Matsubara H.
    • Koide Y.
    • et al.

    Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.

    J Hepatol. 1997; 26: 771-778

    • Poussin K.
    • Dienes H.
    • Sirma H.
    • Urban S.
    • Beaugrand M.
    • Franco D.
    • et al.

    Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.

    Int J Cancer. 1999; 80: 497-505

    • Chami M.
    • Gozuacik D.
    • Saigo K.
    • Capiod T.
    • Falson P.
    • Lecoeur H.
    • et al.

    Hepatitis B virus-related insertional mutagenesis implicates SERCA1 gene in the control of apoptosis.

    Oncogene. 2000; 19: 2877-2886

    • Pollicino T.
    • Vegetti A.
    • Saitta C.
    • Ferrara F.
    • Corradini E.
    • Raffa G.
    • et al.

    Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma.

    J Hepatol. 2013; 58: 190-193

    • Tamori A.
    • Nishiguchi S.
    • Kubo S.
    • Narimatsu T.
    • Habu D.
    • Takeda T.
    • et al.

    HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.

    J Med Virol. 2003; 71: 492-498

    • Fujimoto Y.
    • Hampton L.L.
    • Wirth P.J.
    • Wang N.J.
    • Xie J.P.
    • Thorgeirsson S.S.

    Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.

    Cancer Res. 1994; 54: 281-285

    • Unsal H.
    • Yakicier C.
    • Marcais C.
    • Kew M.
    • Volkmann M.
    • Zentgraf H.
    • et al.

    Genetic heterogeneity of hepatocellular carcinoma.

    Proc Natl Acad Sci U S A. 1994; 91: 822-826

    • Matsuzaki Y.
    • Chiba T.
    • Hadama T.
    • Asaoka H.
    • Doy M.
    • Shoda J.
    • et al.

    HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.

    Cancer Lett. 1997; 119: 53-61

    • Paterlini P.
    • Poussin K.
    • Kew M.
    • Franco D.
    • Brechot C.

    Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.

    Hepatology. 1995; 21: 313-321

    • Hsia C.C.
    • Nakashima Y.
    • Tabor E.

    Deletion mutants of the hepatitis B virus X gene in human hepatocellular carcinoma.

    Biochem Biophys Res Commun. 1997; 241: 726-729

    • Iavarone M.
    • Trabut J.B.
    • Delpuech O.
    • Carnot F.
    • Colombo M.
    • Kremsdorf D.
    • et al.

    Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection.

    J Hepatol. 2003; 39: 253-261

    • Sirma H.
    • Weil R.
    • Rosmorduc O.
    • Urban S.
    • Israel A.
    • Kremsdorf D.
    • et al.

    Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome.

    Oncogene. 1998; 16: 2051-2063

    • Tu H.
    • Bonura C.
    • Giannini C.
    • Mouly H.
    • Soussan P.
    • Kew M.
    • et al.

    Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.

    Cancer Res. 2001; 61: 7803-7810

    • Hatazawa Y.
    • Yano Y.
    • Okada R.
    • Tanahashi T.
    • Hayashi H.
    • Hirano H.
    • et al.

    Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection.

    Infect Agent Cancer. 2018; 13: 7

    • Pollicino T.
    • Cacciola I.
    • Saffioti F.
    • Raimondo G.

    Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications.

    J Hepatol. 2014; 61: 408-417

    • Huo T.I.
    • Wu J.C.
    • Lee P.C.
    • Chau G.Y.
    • Lui W.Y.
    • Tsay S.H.
    • et al.

    Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

    Hepatology. 1998; 28: 231-236

    • Chen Y.C.
    • Sheen I.S.
    • Chu C.M.
    • Liaw Y.F.

    Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection.

    Gastroenterology. 2002; 123: 1084-1089

    • Yuen M.F.
    • Wong D.K.
    • Sablon E.
    • Tse E.
    • Ng I.O.
    • Yuan H.J.
    • et al.

    HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

    Hepatology. 2004; 39: 1694-1701

    • Ahn S.H.
    • Park Y.N.
    • Park J.Y.
    • Chang H.Y.
    • Lee J.M.
    • Shin J.E.
    • et al.

    Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

    J Hepatol. 2005; 42: 188-194

    • Michalak T.I.
    • Pasquinelli C.
    • Guilhot S.
    • Chisari F.V.

    Hepatitis B virus persistence after recovery from acute viral hepatitis.

    J Clin Invest. 1994; 93: 230-239

    • Yotsuyanagi H.
    • Yasuda K.
    • Iino S.
    • Moriya K.
    • Shintani Y.
    • Fujie H.
    • et al.

    Persistent viremia after recovery from self-limited acute hepatitis B.

    Hepatology. 1998; 27: 1377-1382

    • Yuki N.
    • Nagaoka T.
    • Yamashiro M.
    • Mochizuki K.
    • Kaneko A.
    • Yamamoto K.
    • et al.

    Long-term histologic and virologic outcomes of acute self-limited hepatitis B.

    Hepatology. 2003; 37: 1172-1179

    • Kannangai R.
    • Vivekanandan P.
    • Netski D.
    • Mehta S.
    • Kirk G.D.
    • Thomas D.L.
    • et al.

    Liver enzyme flares and occult hepatitis B in persons with chronic hepatitis C infection.

    J Clin Virol. 2007; 39: 101-105

    • Chemin I.
    • Guillaud O.
    • Queyron P.C.
    • Trepo C.

    Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection.

    J Hepatol. 2009; 51: 824-825

    • Terrault N.A.
    • Lok A.S.F.
    • McMahon B.J.
    • Chang K.M.
    • Hwang J.P.
    • Jonas M.M.
    • et al.

    Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

    Hepatology. 2018; 67: 1560-1599

  • Source Link

    Related Articles

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: